Klotho Neurosciences, Inc.

NasdaqGM:KLTO Stock Report

Market Cap: US$10.0m

Klotho Neurosciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Joe Sinkule

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Joe Sinkule (70 yo)

less than a year

Tenure

Dr. Joseph Sinkule, also known as Joe, Pharm D, is Founder, Chief Executive Officer, Chairman of the Board & Secretary of Klotho Neurosciences, Inc. (formerly known as Anew Medical, Inc.) 2024 and was its...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Moriarty
Chief Operating Officerless than a yearUS$10.00k0.94%
$ 94.0k
Shalom Hirschman
Medical Advisor & Directorless than a yearUS$65.00k1.88%
$ 188.0k
Joseph Sinkule
Founderno datano datano data
Jeffrey LeBlanc
Chief Financial Officerless than a yearno datano data
Miguel Rodriguez
Chief Scientific Officer & Consultantless than a yearno datano data
Bradford Navia
Chief Medical Advisorno datano datano data

0.6yrs

Average Tenure

69.5yo

Average Age

Experienced Management: KLTO's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Shalom Hirschman
Medical Advisor & Directorno dataUS$65.00k1.88%
$ 188.0k
Joseph Sinkule
Founderless than a yearno datano data
Robert S. Langer
Member of Scientific Advisory Boardless than a yearno datano data
Jon McGarity
Independent Directorless than a yearno data0.14%
$ 14.1k
Samuel Zentman
Independent Directorless than a yearno datano data
Merit Cudkowicz
Member of Scientific Advisory Boardno datano datano data
Bradley Willcox
Member of Scientific Advisory Boardno datano datano data
Riad El-Dada
Directorless than a yearno datano data
Makoto Kuro-O
Member of Scientific Advisory Boardless than a yearno datano data
D. Willcox
Member of Scientific Advisory Boardno datano datano data
Michio Shimabukuro
Member of Scientific Advisory Boardno datano datano data
Richard Allsopp
Member of Scientific Advisory Boardno datano datano data

0.3yrs

Average Tenure

75yo

Average Age

Experienced Board: KLTO's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 18:27
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Klotho Neurosciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution